Northern Trust
WHWK

Northern Trust’s Whitehawk Therapeutics WHWK Stock Holding History

Northern Trust’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Buy
107,266
+3,814
+4% +$11.9K ﹤0.01% 3727
2025
Q4 		$250K Buy
103,452
+31,288
+43% +$71.8K ﹤0.01% 3900
2025
Q3 		$137K Sell
72,164
-20,111
-22% -$37K ﹤0.01% 4066
2025
Q2 		$173K Buy
92,275
+5,952
+7% +$10.4K ﹤0.01% 3987
2025
Q1 		$154K Sell
86,323
-4,828
-5% -$12.6K ﹤0.01% 4011
2024
Q4 		$288K Buy
91,151
+22,677
+33% +$51.4K ﹤0.01% 3860
2024
Q3 		$141K Sell
68,474
-90,206
-57% -$146K ﹤0.01% 3977
2024
Q2 		$232K Sell
158,680
-124
-0.1% -$230 ﹤0.01% 3814
2024
Q1 		$372K Sell
158,804
-3,559
-2% -$6.86K ﹤0.01% 3659
2023
Q4 		$328K Buy
162,363
+21,215
+15% +$89K ﹤0.01% 3692
2023
Q3 		$683K Buy
141,148
+12,825
+10% +$74.5K ﹤0.01% 3426
2023
Q2 		$878K Buy
128,323
+7,992
+7% +$62.1K ﹤0.01% 3412
2023
Q1 		$871K Sell
120,331
-2,174
-2% -$23.2K ﹤0.01% 3270
2022
Q4 		$1.57M Sell
122,505
-3,861
-3% -$50.4K ﹤0.01% 3111
2022
Q3 		$1.79M Sell
126,366
-7,858
-6% -$103K ﹤0.01% 3071
2022
Q2 		$1.65M Buy
134,224
+97,966
+270% +$1.46M ﹤0.01% 3160
2022
Q1 		$615K Sell
36,258
-550
-1% -$10.5K ﹤0.01% 3656
2021
Q4 		$889K Buy
+36,808
New +$924K ﹤0.01% 3590
2021
Q3 		– Sell
-3,707
Closed -$94K – 4756
2021
Q2 		$94K Hold
3,707
– – ﹤0.01% 4377
2021
Q1 		$72K Hold
3,707
– – ﹤0.01% 4338
2020
Q4 		$54K Sell
3,707
-63
-2% -$1.35K ﹤0.01% 4228
2020
Q3 		$85K Buy
3,770
+423
+13% +$8.9K ﹤0.01% 3999
2020
Q2 		$63K Sell
3,347
-171
-5% -$2.24K ﹤0.01% 4015
2020
Q1 		$29K Hold
3,518
– – ﹤0.01% 4036
2019
Q4 		$33K Hold
3,518
– – ﹤0.01% 4101
2019
Q3 		$36K Hold
3,518
– – ﹤0.01% 4090
2019
Q2 		$48K Hold
3,518
– – ﹤0.01% 4088
2019
Q1 		$48K Buy
+3,518
New +$151K ﹤0.01% 4045

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Northern Trust's WHWK Position: Q1 2026 in Review

Northern Trust increased its Whitehawk Therapeutics (WHWK) stake by 3.7% in Q1 2026, buying an estimated $11.9K and bringing the position to 107,266 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #3727.

Northern Trust first reported a position in WHWK in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.79M in Q3 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Northern Trust held 107,266 shares of Whitehawk Therapeutics worth $370K as of Q1 2026.
  • Northern Trust bought 3,814 Whitehawk Therapeutics shares in Q1 2026, an estimated $11.9K.
  • Whitehawk Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3727 holding.
  • Northern Trust first reported a position in Whitehawk Therapeutics in Q1 2019 and has held it in 28 quarters since.
  • Northern Trust's Whitehawk Therapeutics position peaked at $1.79M in Q3 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.